Mantle cell lymphoma tends to grow quickly. When doctors find this type of cancer, it’s usually widespread throughout your body already. This can make treatment more difficult. But doctors have ...

Amneal and Shilpa are releasing Boruzu, a new presentation of bortezomib for ready-to-use subcutaneous administration or ...

EMA committee recommends approval of AstraZeneca’s Calquence plus chemoimmunotherapy to treat adult patients with mantle cell lymphoma: Cambridge, UK Tuesday, April 1, 2025, 17: ...

High-dose chemotherapy and HSCT can provide long-term benefits in patients with MCL, a retrospective study suggests.

Calquence in combination with bendamustine and rituximab has been recommended for approval in the European Union, EU, for ...

Mantle cell lymphoma grows slowly but can be hard to ... Here are some questions to get you started. The type of treatment you get depends on your overall health, the type of lymphoma you have ...

AstraZeneca has received another boost to its aspirations in oncology with the FDA approval of Calquence, a next generation treatment for mantle cell lymphoma (MCL). Calquence (acalabrutinib ...

AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Union (EU) for the treatment of adult patients with previously ...

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

In the European Union, the agent is approved for the treatment of relapsed/refractory follicular ... including diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone ...